Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingye Wu

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 13, 2025
Correlation Between the Controlled Attenuation Parameter and the Prevalence of T2DM in Southern China: A Retrospective Cross-Sectional StudyXingye Wu, Ruibing Qi, Jiaqin Jiang, et al.
Reproductive Biology and Endocrinology : RB&E|March 21, 2024
Liraglutide improved the reproductive function of obese mice by upregulating the testicular AC3/cAMP/PKA pathwayRuibing Qi, Yuzhen Liang, Jinming Yu, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Design, Synthesis, and Evaluation of 8-(<i>o</i>-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 AntagonistsXingye Wu, He Li, Han Liu, et al.
Journal of Computer-Aided Molecular Design|July 18, 2025
Design, synthesis, evaluation and molecular modeling of quinazoline derivatives bearing amino acids as small-molecule PD-L1 inhibitorsHan Liu, Roufen Chen, Dandan Yuan, et al.
RSC Advances|September 29, 2023
Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostatYali Gao, Fei Li, Xin Ni, et al.
Journal of Clinical Pharmacy and Therapeutics|June 2, 2020
Therapeutic drug monitoring-based dose optimization for imatinib-associated serious cutaneous reactions in a patient with gastrointestinal stromal tumours: A case reportWanting Huang, Juan Li, Feng Qiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2023
Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular DiseaseSara H Bares, Xingye Wu, Katherine Tassiopoulos, et al.
Journal of Medical Ultrasonics (2001)|March 28, 2025
The role of ultrasound in assessment and prediction of the efficacy of preoperative targeted therapy for gastrointestinal mesenchymal tumors compared with pathologyPing Yang, XiuJun Li, ChonQing Chen, et al.
BMC Infectious Diseases|January 14, 2015
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE studyJohn A Crump, Xingye Wu, Michelle A Kendall, et al.
Molecular Diversity|May 11, 2024
Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelatorsHe Li, Yali Gao, Xin Ni, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 13, 2025
Correlation Between the Controlled Attenuation Parameter and the Prevalence of T2DM in Southern China: A Retrospective Cross-Sectional StudyXingye Wu, Ruibing Qi, Jiaqin Jiang, et al.
Reproductive Biology and Endocrinology : RB&E|March 21, 2024
Liraglutide improved the reproductive function of obese mice by upregulating the testicular AC3/cAMP/PKA pathwayRuibing Qi, Yuzhen Liang, Jinming Yu, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Design, Synthesis, and Evaluation of 8-(<i>o</i>-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 AntagonistsXingye Wu, He Li, Han Liu, et al.
Journal of Computer-Aided Molecular Design|July 18, 2025
Design, synthesis, evaluation and molecular modeling of quinazoline derivatives bearing amino acids as small-molecule PD-L1 inhibitorsHan Liu, Roufen Chen, Dandan Yuan, et al.
RSC Advances|September 29, 2023
Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostatYali Gao, Fei Li, Xin Ni, et al.
Journal of Clinical Pharmacy and Therapeutics|June 2, 2020
Therapeutic drug monitoring-based dose optimization for imatinib-associated serious cutaneous reactions in a patient with gastrointestinal stromal tumours: A case reportWanting Huang, Juan Li, Feng Qiu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2023
Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular DiseaseSara H Bares, Xingye Wu, Katherine Tassiopoulos, et al.
Journal of Medical Ultrasonics (2001)|March 28, 2025
The role of ultrasound in assessment and prediction of the efficacy of preoperative targeted therapy for gastrointestinal mesenchymal tumors compared with pathologyPing Yang, XiuJun Li, ChonQing Chen, et al.
BMC Infectious Diseases|January 14, 2015
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE studyJohn A Crump, Xingye Wu, Michelle A Kendall, et al.
Molecular Diversity|May 11, 2024
Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelatorsHe Li, Yali Gao, Xin Ni, et al.
Pageof 8